UMMS Affiliation

Commonwealth Medicine, Center for Health Policy and Research; Department of Family Medicine and Community Health; Department of Quantitative Health Sciences

Date

7-20-2013

Document Type

Presentation

Disciplines

Health Economics | Health Law and Policy | Health Policy | Health Services Administration | Health Services Research | Substance Abuse and Addiction

Abstract

This presentation discusses the impact of prior authorization on Buprenorphine dose, relapse, and cost for opioid addiction treatment for Massachusetts Medicaid members.

Presented at the AcademyHealth Annual Research Meeting 2013.

Keywords

Drug addiction treatment, Medicaid, buprenorphine, pharmaceutical policy, prior authorization, opioid treatment

 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.